(Q34521890)

2 August 2017

1 reference

title

Treatment of clinical stage I germ cell tumors (English)

1 reference

2 August 2017

1

Sam S Chang

1 reference

2 August 2017

Bruce Roth

2

1 reference

PubMed ID

11834380

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

59

1 reference

2 August 2017

2

1 reference

2 August 2017

173-179

1 reference

Surveillance for stage I testicular seminoma. Is it a good option?

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

The management of stage I testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

A rational approach to managing stage I nonseminomatous germ cell cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Staging of testis cancer. Combining serum markers, histologic parameters, and radiographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Late relapse of testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Accuracy of Preoperative Staging in Stages A and B Nonseminomatous Germ Cell Testis Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Treatment-Associated Leukemia Following Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Radiation therapy for early stage seminoma of the testis. Analysis of survival and gastrointestinal toxicity in patients treated with modern megavoltage techniques over 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Second malignancies following pure seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Radiotherapy for stages I and IIA/B testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Surveillance following orchidectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Surveillance following orchidectomy for stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

Complications of therapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901532-1

7 January 2021

10.1016/S0090-4295(01)01532-1

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11834380